StockData
Pulmatrix, Inc. logo

Pulmatrix, Inc. (PULM) stock

PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.34−0.03 (-2.19%)

Close on Nov 18, 2026Market cap $4.89MP/E –Yield –

Pulmatrix revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Pulmatrix's revenue for the twelve months ending Dec 31, 2024 was $7.81M, up 7.0% year over year. For fiscal 2024 it was $7.81M, up 7.0% from the year before. Over ten years it grew 36.3% a year on average. The highest annual figure on record is $12.63M in fiscal 2020.

Annual revenue

PeriodPeriod endValueChange
FY2024Dec 31, 2024$7.81M+7.0%
FY2023Dec 31, 2023$7.30M+20.2%
FY2022Dec 31, 2022$6.07M+17.5%
FY2021Dec 31, 2021$5.17M-59.1%
FY2020Dec 31, 2020$12.63M+59.7%
FY2019Dec 31, 2019$7.91M+5069.9%
FY2018Dec 31, 2018$153.00K-54.3%
FY2017Dec 31, 2017$335.00K-59.9%
FY2016Dec 31, 2016$835.00K-30.5%
FY2015Dec 31, 2015$1.20M+241.2%
FY2014Dec 31, 2014$352.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$3.00K-99.9%
Q3 FY2024Sep 30, 2024$366.00K-79.1%
Q2 FY2024Jun 30, 2024$1.55M-15.8%
Q1 FY2024Mar 31, 2024$5.89M+292.6%
Q4 FY2023Dec 31, 2023$2.20M+28.9%
Q3 FY2023Sep 30, 2023$1.75M-6.4%
Q2 FY2023Jun 30, 2023$1.84M+38.5%
Q1 FY2023Mar 31, 2023$1.50M+29.2%
Q4 FY2022Dec 31, 2022$1.71M+274.6%
Q3 FY2022Sep 30, 2022$1.87M+75.1%
Q2 FY2022Jun 30, 2022$1.33M-40.9%
Q1 FY2022Mar 31, 2022$1.16M-16.5%
Q4 FY2021Dec 31, 2021$456.00K-77.2%
Q3 FY2021Sep 30, 2021$1.07M-75.5%
Q2 FY2021Jun 30, 2021$2.25M-35.6%
Q1 FY2021Mar 31, 2021$1.39M-49.7%
Q4 FY2020Dec 31, 2020$2.00M+18.7%
Q3 FY2020Sep 30, 2020$4.37M+211.0%
Q2 FY2020Jun 30, 2020$3.50M-27.4%
Q1 FY2020Mar 31, 2020$2.76M+1705.2%
Q4 FY2019Dec 31, 2019$1.69M–
Q3 FY2019Sep 30, 2019$1.41M–
Q2 FY2019Jun 30, 2019$4.82M+3049.7%
Q4 FY2018Dec 31, 2018$153.00K–
Q3 FY2018Sep 30, 2018$0-100.0%
Q2 FY2018Jun 30, 2018$0-100.0%
Q1 FY2018Mar 31, 2018$153.00K–
Q4 FY2017Dec 31, 2017$0–
Q3 FY2017Sep 30, 2017$335.00K–
Q4 FY2016Dec 31, 2016$117.00K–

More Pulmatrix figures

See a number that looks wrong?